Futures Slide As Bond Yields Jump To 6 Month High
Slightly above 67% of RAPT Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding RAPT Therapeutics suggests that many traders are alarmed. RAPT Therapeutics' investing sentiment can be driven by a variety of factors including economic data, RAPT Therapeutics' earnings reports, geopolitical events, and overall market trends.
RAPT |
US stock futures and Treasuries dropped as muted trading resumed after the Christmas holiday, with investors looking to initial jobless claims data and a government bond auction later on Thursday.
Read at talkmarkets.com
 |
RAPT Therapeutics Fundamental Analysis
We analyze RAPT Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RAPT Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RAPT Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
RAPT Therapeutics is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
RAPT Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RAPT Therapeutics stock to make a market-neutral strategy. Peer analysis of RAPT Therapeutics could also be used in its relative valuation, which is a method of valuing RAPT Therapeutics by comparing valuation metrics with similar companies.
Peers
RAPT Therapeutics Related Equities
| CNTB | Connect Biopharma | 17.53 | ||||
| HCWB | HCW Biologics | 5.00 | ||||
| ANEB | Anebulo Pharmaceuticals | 4.94 | ||||
| ANTX | AN2 Therapeutics | 4.35 | ||||
| MOLN | Molecular Partners | 0.19 | ||||
| PHVS | Pharvaris | 0.36 | ||||
| MLYS | Mineralys Therapeutics, | 0.39 | ||||
| ARVN | Arvinas | 0.42 | ||||
| PMVP | Pmv Pharmaceuticals | 0.66 | ||||
| XLO | Xilio Development | 1.02 | ||||
| STOK | Stoke Therapeutics | 1.60 | ||||
| IKNA | Ikena Oncology | 1.91 | ||||
| RLAY | Relay Therapeutics | 2.02 | ||||
| GLUE | Monte Rosa | 2.22 | ||||
| HOWL | Werewolf Therapeutics | 2.52 | ||||
| PLRX | Pliant Therapeutics | 3.35 | ||||
| DSGN | Design Therapeutics | 3.70 | ||||
| TYRA | Tyra Biosciences | 4.29 | ||||
| BDTX | Black Diamond | 4.78 | ||||
| PEPG | PepGen | 8.41 |
Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.